US: The FDA answers device´s importers questions during COVID-19

2024-02-29T17:10:45+00:00August 13th, 2020|Categories: Clinical Trial, Compliance, Covid-19, USA|Tags: , , , |

The Food and Drug Administration has published two new webpages with instructions on medical device importation, registration and listing amid  COVID-19. Meditrial is there to help! - Reach out to us for any kind of assistance in regard of [...]

EU: Medical Device Single Audit Program guidance by the EU Commission’s Medical Device Coordination Group

2024-02-23T16:35:16+00:00August 11th, 2020|Categories: Compliance, Europe, Regulatory|Tags: , , , , , |

The EU Commission’s Medical Device Coordination Group issued a guidance providing details on how notified bodies can reference Medical Device Single Audit Program  audit reports when planning surveillance audits under the MDR or IVDR. Meditrial can help you to [...]

US: FDA publishes user fee amounts for medical device manufacturers in 2021

2024-02-29T17:06:35+00:00August 3rd, 2020|Categories: Clinical Trial, Software, USA|

The FDA has recently published the user fee amounts which will be collected from medical device manufacturers in fiscal year 2021. Meditrial is the partner for medical device manufacturers in the US. Reach out to Meditrial for clinical or [...]

US: FDA issues final guidance on multiple function device products

2024-02-29T16:48:12+00:00July 29th, 2020|Categories: Clinical Trial, Software, USA|Tags: , |

The FDA finalized a guidance for sponsors regarding the FDA´s review of medical products that contain both medical and non-medical functions. Meditrial has extensive experience with assisting sponsors in regard of FDA requirements for medical devices and software as [...]

US: FDA exempts additional Class II devices from 510(k) requirements

2024-02-29T16:40:22+00:00July 23rd, 2020|Categories: Clinical Trial, Compliance, USA|Tags: , , |

The FDA ordered the exemption five types of Class II medical devices from 510(k) requirements. This decision aims at releaving manufacturers of those devices from some regulatory burden. Meditrial has extensive experience on regulatory matters relating to medical device [...]

Dr. Tocchi lecture for Weill Cornell Medicine

2024-02-02T10:42:51+00:00July 21st, 2020|Categories: Innovation, USA|Tags: , , , , |

How to build a Regulatory and Clinical Strategy. Meditrial is thrilled to partner with Weill Cornell Medicine to help biotechnology inventors be successful in globalhealth. Dr. Monica Tocchi will hold a lecture on regulatory. Register here https://lnkd.in/eT7WNWu For more information, click [...]

The European Commission updates on MDR implementation

2024-02-29T14:40:29+00:00July 20th, 2020|Categories: Clinical Trial, Compliance, Europe, MDR|Tags: , , , , |

The European Commission over the past week provided several updates on the implementation of the Medical Device Regulation (MDR) and released a fact sheet explaining the information that will be available to the public about devices according to transparency [...]

EU agencies commends sponsors to ensure post-Brexit compliance with clinical trial rules

2024-02-02T11:58:44+00:00July 13th, 2020|Categories: Clinical Trial, Compliance, Europe|Tags: , , , |

The European Commission together with the European regulatory agencies EMA (European Medicines Agency) and HMA (Heads of Medicine), released a statement to urge sponsors to comply with clinical trials rules after Brexit. The deadline for compliance is 31st December [...]

US: FDA plans to resume on-site domestic inspections as of 20 July 2020

2024-02-29T16:53:39+00:00July 13th, 2020|Categories: Clinical Trial, Covid-19, USA|Tags: , , , |

The Food and Drug Administration (FDA) announced the plan to resume on-site domestic inspections beginning the week of 20 July 2020. The resume process will be different in each state according to local rules and epidemiological situation. Moreovoer, a [...]

UK: Changes to amendment submission to HRA/MREC

2024-02-29T15:14:45+00:00July 8th, 2020|Categories: Clinical Trial, Europe, UK|Tags: , , |

On 2 June 2020 changes were introduced in the Integrated Research Application System (IRAS) to the way amendments are notified to Research Ethics Committees and NHS/HSC in the UK: Project-based research should now prepare amendments using the Amendment Tool. Amendments [...]

Go to Top